In this article

Empty vials of the Pfizer COVID-19 vaccine are seen at a first come first serve drive-thru vaccination site operated by the Lake County Health Department on January 28, 2021 in Groveland, Florida.
Paul Hennessy | NurPhoto | Getty Images

The Food and Drug Administration is working to approve the Pfizer and BioNTech Covid-19 vaccine on Monday, The New York Times reported, citing sources.

The review process could move past that date, The Times said, as paperwork and negotiations with the company continue.

The move would make it the first vaccine to go from emergency use authorization to full FDA approval.

The FDA declined to comment on the Times report to CNBC.

Pfizer and BioNTech initially began the process of applying for their biologics license for the two-dose vaccine in May after receiving emergency use authorization from the FDA last December. The FDA sets a six-month target for approving high-priority drugs and a 10-month target for all other standard drugs.

The companies announced Monday that they began the approval process for their third booster dose after submitting clinical trial data to the FDA.

Top health officials from agencies including the CDC and FDA said in a statement Wednesday that the effectiveness of mRNA vaccines declines over time, especially for those with compromised immune systems or for anyone inoculated early in the vaccine rollout.

You May Also Like

Juul asks court for temporary block on FDA’s ban of its e-cigarettes

Juul brand vape cartridges are pictured for sale at a shop in…
The next big career track at business schools: Family offices

The next big career track at business schools: Family offices

The University of Chicago Booth School of Business. Courtesy: The University of…

U.S. will limit next generation Covid vaccines to high-risk people this fall if Congress doesn’t approve more funding

A woman receives a Pfizer vaccination booster shot at Eugene A. Obregon…

Tyson Foods to lay off 1,700 workers, close two chicken plants

In this article TSN Follow your favorite stocksCREATE FREE ACCOUNT A package…